Lockheed Martin Corp. (LMT.US) released its Q4 2024 earnings report today, with shares declining up to 3.5% in premarket trading as the defense giant grappled with significant losses on classified programs and issued lower-than-expected 2025 guidance. Despite a record backlog demonstrating strong global demand, the company faces challenges with program execution and technology upgrades.
Q4 2024 Results:
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile app- Revenue: $18.62 billion (-1.3% YoY) vs $18.84 billion expected
- EPS: $2.22 vs $7.58 YoY
- Operating profit: $696.0 million (-70% YoY) vs $2.07 billion expected
- Free cash flow: $441.0 million (-73% YoY) vs $1.26 billion expected
- Backlog: $176.04 billion (+9.6% YoY)
Segment Performance:
- Aeronautics: $8.01 billion revenue (+5.2% YoY), $434 million operating profit (-43% YoY)
- Missiles and Fire Control: $3.41 billion revenue (+7.6% YoY), $804 million operating loss
- Rotary and Mission Systems: $4.26 billion revenue (-9.6% YoY), $513 million operating profit (-11% YoY)
- Space: $2.94 billion revenue (-13% YoY), $283 million operating profit (-7.8% YoY)
2025 Financial Outlook:
- Net sales: $73.75-74.75 billion vs $74.02 billion expected
- EPS: $27.00-27.30 vs $27.82 expected
- Free cash flow: $6.60-6.80 billion vs $6.45 billion expected
- Business segment operating profit: $8.10-8.20 billion
- Capital expenditure: ~$1.90 billion
Significant Program Impacts:
- Booked $2 billion in losses on classified programs in 2024
- $1.4 billion loss in Missiles and Fire Control portfolio
- $555 million overrun in Aeronautics division
- F-35 program experiencing delays in Technology Refresh 3 upgrade rollout
- Delivered 62 F-35 aircraft in Q4
CEO Commentary: Jim Taiclet highlighted the company's 5% sales growth and record backlog as evidence of strong global demand for advanced defense technology. He characterized 2024 as "successful and productive" despite significant program challenges.
Lockheed Martin Corp. (LMT.US D1 Interval)
The stock is trading slightly below the 30-day SMA in premarket. Bears will aim for a retest of January lows at $460, while bulls will attempt to break the resistance at the 23.6% Fibonacci retracement level, which is beginning to coincide with the 50-day SMA. The RSI is likely to show signs of bearish divergence, while the MACD is expected to tighten at market open. Source: xStation
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
